JNJ Dividends
Johnson & Johnson (JNJ) pays $5.24 in dividends per share, with a current dividend yield of 2.21%. The company has dividend history for 62 consecutive years.
JNJ Dividend Summary
2.21%
$5.24
47.51%
71.50%
Consecutive Years
62
Most Recent Ex-Date
May 26, 2026
Most Recent Payment
Jun 9, 2026
JNJ Dividends per Share (Nominal History)
View full nominal table listThis step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.
JNJ Dividends CAGR Chart
Johnson & Johnson (JNJ)
Annual Dividend History
| Year | Dividend/Share | YoY Growth |
|---|---|---|
| 2026(YTD) | $2.64 | — |
| 2025 | $5.14 | +4.68% |
| 2024 | $4.91 | +4.47% |
| 2023 | $4.70 | +5.62% |
| 2022 | $4.45 | +6.21% |
| 2021 | $4.19 | +5.28% |
| 2020 | $3.98 | +6.13% |
| 2019 | $3.75 | +5.93% |
| 2018 | $3.54 | +6.63% |
| 2017 | $3.32 | +5.40% |
| 2016 | $3.15 | +6.78% |
| 2015 | $2.95 | +6.88% |
| 2014 | $2.76 | +6.56% |
| 2013 | $2.59 | +7.92% |
| 2012 | $2.40 | +6.67% |
| 2011 | $2.25 | +6.64% |
| 2010 | $2.11 | +9.33% |
| 2009 | $1.93 | +7.52% |
| 2008 | $1.79 | +10.80% |
| 2007 | $1.62 | +11.34% |
Quarterly Dividend History
| Quarter | Dividend/Share | YoY Growth |
|---|---|---|
| Q2 2026 | $1.34 | +3.08% |
| Q1 2026 | $1.30 | +4.84% |
| Q4 2025 | $1.30 | +4.84% |
| Q3 2025 | $1.30 | +4.84% |
| Q2 2025 | $1.30 | +4.84% |
| Q1 2025 | $1.24 | +4.20% |
| Q4 2024 | $1.24 | +4.20% |
| Q3 2024 | $1.24 | +4.20% |
| Q2 2024 | $1.24 | +4.20% |
| Q1 2024 | $1.19 | +5.31% |
| Q4 2023 | $1.19 | +5.31% |
| Q3 2023 | $1.19 | +5.31% |
| Q2 2023 | $1.19 | +5.31% |
| Q1 2023 | $1.13 | +6.60% |
| Q4 2022 | $1.13 | +6.60% |
| Q3 2022 | $1.13 | +6.60% |
| Q2 2022 | $1.13 | +6.60% |
| Q1 2022 | $1.06 | +4.95% |
| Q4 2021 | $1.06 | +4.95% |
| Q3 2021 | $1.06 | +4.95% |
| Q2 2021 | $1.06 | +4.95% |
| Q1 2021 | $1.01 | +6.32% |
| Q4 2020 | $1.01 | +6.32% |
| Q3 2020 | $1.01 | +6.32% |
Dividend Yield Metrics
- Current Yield
- 2.21%
- Average Yield (TTM)
- 2.21%
- Average Yield (3Y)
- 2.07%
- Forward Yield on Cost (3Y)
- 2.71%
- Forward Yield on Cost (5Y)
- 3.11%
- Forward Yield on Cost (10Y)
- 4.37%
Payout Ratio Analysis
- Payout Ratio (Current)
- 47.51%
- FCF Payout Ratio
- 71.50%
- Payout Ratio (3Y Avg)
- 66.50%
- Payout Ratio (5Y Avg)
- 66.11%
- FCF Payout (3Y Avg)
- 64.81%
- FCF Payout (5Y Avg)
- 61.65%
Dividend Coverage
About Johnson & Johnson
Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Joaquin Duato